Navigation und Service


Publikationen 2011 zum Thema HIV/AIDS

Bätzing-Feigenbaum J, Kollan C, Kuehne A, Matysiak-Klose D, Gunsenheimer-Bartmeyer B, Hamouda O; ClinSurv Study Group (2011): Cohort profile: the German ClinSurv HIV project – a multicentre open clinical cohort study supplementing national HIV surveillance.
HIV Med. 12 (5): 269-278. Epub 2010 Oct 18. DOI: 10.1111/j.1468-1293.2010.00879.x.

Hauser A, Mugenyi K, Kabasinguzi R, Kücherer C et al. (2011): Emergence and persistence of minor drug-resistant HIV-1 variants in Ugandan women after Nevirapine single-dose prophylaxis.
PLoS ONE 6 (5): e20357. DOI: 10.1371/journal.pone.0020357.

Jaffe HWet al.; CASCADE Collaboration (for GermanyHamouda O, Kücherer C, Bartmeyer B) (2011): Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults.
AIDS 25 (11): 1395–1403.

Jarrin I, Pantazis N, Gill MJ, Geskus R, Perez-Hoyos S, Meyer L, Prins M, Touloumi G, Johnson A, Hamouda O et al.; CASCADE Collaboration in EuroCoord (for Germany Hamouda O, Kücherer C, Bartmeyer B) (2011): Uptake of Combination Antiretroviral Therapy (cART) and HIV Disease Progression According to Geographical Origin in Seroconverters in Europe, Canada, and Australia.
Clin. Infect. Dis.: Epub Nov 21. doi: 10.1093/cid/cir814.

Marcus U, Schmidt AJ, Hamouda O (2011): HIV serosorting among HIV-positive men who have sex with men is associated with increased self-reported incidence of bacterial sexually transmissible infections.
Sexual Health 8 (2): 184–193. doi:10.1071/SH10053.

Marcus U (2011): Postexpositions-Prophylaxe nach Sex mit potenziell HIV-Infiziertem.
MMW Fortschr. Med. 153 (18): 35-37.

Mussini C et al.; CASCADE Collaboration (for Germany Hamouda O, Kücherer C) (2011): Decline of CD4⁺ T-cell count before start of therapy and immunological response to treatment in antiretroviral-naive individuals.
AIDS 25 (8): 1041-1049.

Norley S (2011): AIDS vaccines: the unfolding story.
In: SHE Kaufmann, B Rouse, D Sacks (Hrsg), The Immune Response to Infection. Weinheim: Wiley VCH, pp. 611–621.

Pilger D, Hauser A, Kücherer C, Mugenyi K, Kabasinguzi R, Somogyi S et al. (2011): Minor drug-resistant HIV type-1 variants in breast milk and plasma of HIV type-1-infected Ugandan women after nevirapine single-dose prophylaxis.
Antivir. Ther. 16 (1): 109–113.

Schmidt AJ, Rockstroh J, Vogel M, an der Heiden M, Baillot A, Krznaric I, Radun D (2011): Trouble with bleeding: Risk factors for acute hepatitis C among HIV-positive gay men from Germany-A case-control study.
PLoS ONE 6 (3): e17781. DOI: 10.1371/journal.pone.0017781.

Schmidt AJ, Marcus U (2011): Self-reported history of sexually transmissible infections (STIs) and STI-related utilization of the German health care system by men who have sex with men: data from a large convenience sample.
BMC Infect. Dis. 11: 132. Epub May 18. doi: 10.1186/1471-2334-11-132.

Stoll M, Kollan C, Bergmann F, Bogner J, Faetkenheuer G, Fritzsche C, Hoeper K, Horst HA, van Lunzen J, Plettenberg A, Reuter S, Rockstroh J, Stellbrink HJ, Hamouda O, Bartmeyer B and the ClinSurv Study Group (2011): Calculation of direct antiretroviral treatment costs and potential cost savings by using generics in the German HIV ClinSurv Cohort.
PLoS One 6 (9): e23946. Epub Sep 9.

Tammer I, Tintelnot K et al. (2011): Infections due to Pseudallescheria/Scedosporium species in patients with advanced HIV disease - a diagnostic and therapeutic challenge.
Int. J. Infect. Dis. 15 (6): e422-e429. Epub Apr 19.

van der Helm J, Prins M, Del Amo J, Bucher HC, Chêne G, Dorrucci M, Gill MJ, Hamouda O et al.; on behalf of the CASCADE collaboration (weitere RKI-Mitarbeiterinnen Kücherer C, Bartmeyer B) (2011): The Hepatitis C epidemic among HIV-positive men who have sex with men: incidence estimates from 1990 to 2007.
AIDS 25 (8): 1083-1091. Epub Apr 18. doi: 10.1097/QAD.0b013e3283471cce.

Votteler J, Neumann L, Hahn S, Hahn F, Rauch P, Schmidt K, Studtrucker N, Solbak SM, Fossen T, Henklein P, Ott DE, Holland G, Bannert N, Schubert U (2011): Highly conserved serine residue 40 in HIV-1 p6 regulates capsid processing and virus core assembly.
Retrovirology 8 (1): 11. doi:10.1186/1742-4690-8-11.

Wittkop L, Günthard HF, de Wolf F, Dunn D, Cozzi-Lepri A, de Luca A, Kücherer C et al.; for the EuroCoord-CHAIN study group (2011): Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study.
Lancet Infect. Dis. 11 (5): 363-371. Epub Feb 25. doi:10.1016/S1473-3099(11)70032-9.

Zoufaly A, An der Heiden M, Kollan C, Bogner JR, Fätkenheuer G, Wasmuth JC, Stoll M, Hamouda O, van Lunzen J the ClinSurv Study Group (cohort manager Kuehne A) (2011): Clinical Outcome of HIV-Infected Patients with Discordant Virological and Immunological Response to Antiretroviral Therapy.
J. Infect. Dis. 203 (3): 364-371. Epub 2010 Dec 8.

Zoufaly A, An der Heiden M, Marcus U, Hoffmann C, Stellbrink HJ, Voss L, Van Lunzen J, Hamouda O (2011): Late presentation for HIV diagnosis and care in Germany.
HIV Medicine: Epub Nov 7.| DOI: 10.1111/j.1468-1293.2011.00958.x.






Das Robert Koch-Institut ist ein Bundesinstitut im Geschäftsbereich des Bundesministeriums für Gesundheit

© Robert Koch-Institut

Alle Rechte vorbehalten, soweit nicht ausdrücklich anders vermerkt.